Brogan Inc.
pic-home
Decrease TextIncrease TextRestore Default
Brogan Inc.
Corporate

PaediatricPrescription medicine use by one million Canadian children

Paediatrics & Child Health
April 2003 . Volume 8 . Supplement A

This study examines trends in paediatric prescribing in Canada based on an administrative database of 4,000,000 claims for one million children during a 12-month period.

Among the key findings is a quantification of drugs prescribed to children outside of the approved age ranges. This study is one tool in the effort to increase research into the appropriate use of drugs in the youngest fraction of the population.

The study received support from Health Canada and the Canadian Paediatric Society and was published in the Paediatrics and Child Health journal.

Report Analysis and Authorship: Brogan Inc.

•  Lama Abi Khaled
•  Fida Ahmad
•  Tom Brogan
•  Joan Fearnley
•  Dr. John Graham ¤
•  Dr. Stuart MacLeod ¤
•  Joan McCormick.

¤ William Osler Health Centre, Brampton, Ontario
¤ British Columbia Research Institute for Children's and
   Women's Health, Vancouver, British Columbia

Funding:
•  AstraZeneca Canada Inc.,
•  Janssen-Ortho Inc.,
•  Eli Lilly Canada Inc.

To request a free copy of this study, call 613.599.0711 or click here to fill out our request form.

Back to Top  

Sub Menu
Overview
The AHW Drug Program Study
Delta
PDP
Paediatric
Login
Corporate
Expertise
Products
Seminars
Publications
News
Careers



Subscribe to our mailing list:

Subscription Form

Copyright